Joshua Silverman Petros Pharmaceuticals, Inc. (PTPI) insider trading activity

Joshua Silverman is Director of Petros Pharmaceuticals, Inc.. Currently has a direct ownership of 4.42 Million shares of PTPI, which is worth approximately $88,309. The most recent transaction as insider was on Jan 02, 2026, when has been sold 4,375,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.42M

336.64% 3M change

39193.85% 12M change

Total Value Held $88,309

Joshua Silverman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2026	BUY Grant, award, or other acquisition	-	4,375,000 Added 49.77%	4,415,450 Common Stock
Feb 19 2025	BUY Grant, award, or other acquisition	-	1,000,000 Added 49.72%	1,011,237 Common Stock
Apr 26 2023	BUY Exercise of conversion of derivative security	-	6,722 Added 37.43%	11,237 Common Stock
Jan 20 2023	BUY Exercise of conversion of derivative security	-	2,515 Added 35.78%	4,515 Common Stock
Dec 01 2020	BUY Grant, award, or other acquisition	-	20,000 Added 50.0%	20,000 Common Stock, par valu...

Also insider at

AYRO

AYRO, Inc. Consumer Cyclical

Chief Executive Officer

MYMD

MyMD Pharmaceuticals, Inc. Healthcare

Executive Chairman

SNPX

Synaptogenix, Inc. Healthcare

Executive Chairman

FEMY

FEMASYS INC Healthcare

PMCB

PharmaCyte Biotech, Inc. Healthcare

CEO and President